首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy
【2h】

Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy

机译:肿瘤渗透T细胞的克隆扩增和对食管鳞状细胞癌中的肿瘤微环境分析在明确的化学疗法后复发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(1) Background: Comparable prognoses after definitive chemoradiation therapy (CRT) to surgery alone for esophageal squamous cell carcinoma (ESCC) have been previously reported; however, no robust prognostic markers have been established. The clonality of tumor-infiltrating lymphocytes (TILs) and tumor microenvironments (TMEs) in ESCC relapsed after CRT were examined to explore prognostic markers. (2) Methods: Clonality of TIL and TME were examined in ESCC with and without preceding CRT, as well as oral squamous cell carcinoma (OSCC) and healthy volunteers as controls. The clonality of TIL was assessed by T-cell receptor (TCR) α and β repertoire analyses and evaluated by diversity indices. The TME was assessed by quantitative polymerase chain reaction evaluating PD-L1 and CD8B. (3) Results: The clonal expansion of TIL was significantly induced within ESCCs and OSCCs, when compared to healthy volunteers, and was mostly induced within ESCCs after definitive CRT. Diversity indices of TIL were not associated with the prognosis, but the ratio of PD-L1 mRNA to CD8B mRNA in TME was significantly associated with a poor prognosis after salvage surgery (p = 0.007). (4) Conclusions: The clonal expansion of TIL is induced after definitive CRT for ESCC, and the ratio of PD-L1 mRNA to CD8B mRNA within tumor tissues is a prognostic marker candidate for salvage esophagectomy after CRT.
机译:(1)背景:先前已经报道了单独用于食管鳞状细胞癌(ESCC)的明确化学疗法治疗(CRT)后的可比预期;但是,没有建立稳健的预后标记。检查CRT后复发在CRT后肿瘤浸润淋巴细胞(TIL)和肿瘤微环境(TME)的克隆性,以探索预后标志物。 (2)方法:在ESCC中检查TIL和TME的克隆性,没有前面的CRT,以及口腔鳞状细胞癌(OSCC)和健康志愿者作为对照。通过T细胞受体(TCR)α和β曲目分析评估TIL的克隆性,并通过多样性指数评估。通过定量聚合酶链反应评估PD-L1和CD8B的分量来评估TME。 (3)结果:与健康志愿者相比,在ESCCS和OSCCS中,TIL的克隆膨胀显着诱导,并且在最终CRT后大多在ESCC中诱导ESCC。 TIL的多样性指数与预后无关,但TME中的PD-L1 mRNA与CD8B mRNA的比率与救人手术后的预后差有显着相关(P = 0.007)。 (4)结论:在确定ESCC的最终CRT后诱导TIL的克隆膨胀,并且PD-L1 mRNA与肿瘤组织中的CD8B mRNA的比率是CRT后挽救食管切除术的预后标志物候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号